Cross-sectional and longitudinal comparisons of the predominant fecal microbiota compositions of a group of pediatric patients with cystic fibrosis and their healthy siblings

Applied and Environmental Microbiology

Volumn 77, Issue 22, 2011, Pages 8015-8024

  Duytschaever, Gwen ^a   Huys, Geert ^a,b   Bekaert, Maarten ^b   Boulanger, Linda ^c   De Boeck, Kris ^c   Vandamme, Peter ^a  

^a GHENT UNIVERSITY   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

16S RRNA; AMPLICONS; ANTIBIOTIC THERAPY; ANTIBIOTIC TREATMENT; BIFIDOBACTERIUM; CROSS-SECTIONAL STUDY; CYSTIC FIBROSIS; DENATURING GRADIENT GEL ELECTROPHORESIS; FECAL MICROBIOTA; HEALTHY SUBJECTS; INTERSUBJECT VARIATION; LACTIC ACID BACTERIA; LONGITUDINAL STUDY; LUNG INFECTION; MICROBIOTAS; PEDIATRIC PATIENTS; SPECIES RICHNESS; STUDY GROUPS; TEMPORAL STABILITY;

ANTIBIOTICS; LACTIC ACID; RNA;

ELECTROPHORESIS;

ANTIINFECTIVE AGENT; BACTERIAL DNA; RIBOSOME DNA; RNA 16S;

ANTIBIOTICS; CHILD HEALTH; COMPARATIVE STUDY; DISEASE TREATMENT; ELECTROKINESIS; FECES; METABOLISM; MICROBIAL COMMUNITY; PUBLIC HEALTH; RESPIRATORY DISEASE; SIBLING; SPECIES RICHNESS;

ARTICLE; BACTERIUM; BIODIVERSITY; CLASSIFICATION; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; CYSTIC FIBROSIS; DENATURING GRADIENT GEL ELECTROPHORESIS; DNA FINGERPRINTING; DRUG EFFECT; FECES; GASTROINTESTINAL TRACT; GENETICS; HUMAN; ISOLATION AND PURIFICATION; LONGITUDINAL STUDY; MICROBIOLOGY; SIBLING;

ANTI-BACTERIAL AGENTS; BACTERIA; BIODIVERSITY; CROSS-SECTIONAL STUDIES; CYSTIC FIBROSIS; DENATURING GRADIENT GEL ELECTROPHORESIS; DNA FINGERPRINTING; DNA, BACTERIAL; DNA, RIBOSOMAL; FECES; GASTROINTESTINAL TRACT; HUMANS; LONGITUDINAL STUDIES; RNA, RIBOSOMAL, 16S; SIBLINGS;

EID: 83055188802     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.05933-11     Document Type: Article

References (76)

1. Andoh, A., et al. 2009. Faecal microbiota profile of Crohn's disease determined by terminal restriction fragment length polymorphism analysis. Aliment. Pharmacol. Ther. 29:75-82.
2. Bartosch, S., A. Fite, G. T. Macfarlane, and M. E. McMurdo. 2004. Characterization of bacterial communities in feces from healthy elderly volunteers and hospitalized elderly patients by using real-time PCR and effects of antibiotic treatment on the fecal microbiota. Appl. Environ. Microbiol. 70: 3575-3581.
3. Bennet, R., M. Eriksson, and C. E. Nord. 2002. The fecal microflora of 1-3-month-old infants during treatment with eight oral antibiotics. Infection 30:158-160.
4. Bik, E. M. 2009. Composition and function of the human-associated microbiota. Nutrition Rev. 67:S164-S171.
5. Björkstén, B., E. Sepp, K. Julge, T. Voor, and M. Mikelsaar. 2001. Allergy development and the intestinal microflora during the first year of life. J. Allergy Clin. Immunol. 108:516-520.
6. Bruzzese, E., et al. 2004. Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration. Aliment Pharmacol. Ther. 20:813-819.
7. Bruzzese, E., et al. 2007. Effect of Lactobacillus GG supplementation on pulmonary exacerbations in patients with cystic fibrosis: a pilot study. Clin. Nutr. 26:322-328.
8. Collado, M. C., M. Calabuig, and Y. Sanz. 2007. Differences between the fecal microbiota of coeliac infants and healthy controls. Curr. Issues Intest. Microbiol. 8:9-14.
9. Conte, M. P., et al. 2006. Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease. Gut 55:1760-1767.
10. Davies, J. C., E. W. Alton, and A. Bush. 2007. Cystic fibrosis. BMJ 335:1255-1259.
11. Di Cagno, R., et al. 2009. Different fecal microbiotas and volatile organic compounds in treated and untreated children with celiac disease. Appl. Environ. Microbiol. 75:3963-3971.
12. Dicksved, J., et al. 2008. Molecular analysis of the gut microbiota of identical twins with Crohn's disease. ISME J. 2:716-727.
13. Donskey, C. J., et al. 2003. Use of denaturing gradient gel electrophoresis for analysis of the stool microbiota of hospitalized patients. J. Microbiol. Methods 54:249-256.
14. Eckburg, P. B., et al. 2005. Diversity of the human intestinal microbial flora. Science 308:1635-1638.
15. Edlund, C., et al. 2000. Comparative effects of moxifloxacin and clarithromycin on the normal intestinal microflora. Scand. J. Infect. Dis. 32:81-85.
16. Engelbrektson, A. L., et al. 2006. Analysis of treatment effects on the microbial ecology of the human intestine. FEMS Microbiol. Ecol. 57:239-250.
17. Favier, C., et al. 1997. Fecal beta-D-galactosidase production and Bifidobacteria are decreased in Crohn's disease. Dig. Dis. Sci. 42:817-822.
18. Gill, S. R., et al. 2006. Metagenomic analysis of the human distal gut microbiome. Science 312:1355-1359.
19. Gophna, U., K. Sommerfeld, S. Gophna, W. F. Doolittle, and S. J. Veldhuyzen van Zanten. 2006. Differences between tissue-associated intestinal microfloras of patients with Crohn's disease and ulcerative colitis. J. Clin. Microbiol. 44:4136-4141.
20. Guarner, F., and J. R. Malagelada. 2003. Gut flora in health and disease. Lancet 361:512-519.
21. Hawrelak, J. A., and S. P. Myers. 2004. The causes of intestinal dysbiosis: a review. Altern. Med. Rev. 9:180-197.
22. Holzapfel, W. H., P. Haberer, J. Snel, U. Schillinger, and J. H. J. Huis in't Veld. 1998. Overview of gut flora and probiotics. Int. J. Food Microbiol. 41:85-101.
23. Hussain, S. Z., C. Chu, D. P. Greenberg, D. Orenstein, and S. Khan. 2004. Clostridium difficile colitis in children with cystic fibrosis. Dig. Dis. Sci. 49:116-121.
24. Iannitti, T., and B. Palmieri. 2010. Therapeutical use of probiotic formulations in clinical practice. Clin. Nutr. 29:701-725.
25. Iapichino, G., et al. 2008. Impact of antibiotics on the gut microbiota of critically ill patients. J. Med. Microbiol. 57:1007-1014.
26. Jakobsson, H. E., et al. 2010. Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. Plos. One 5:e9836.
27. Jernberg, C., S. Lofmark, C. Edlund, and J. K. Jansson. 2007. Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J. 1:56-66.
28. Kalliomäki, M., et al. 2001. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J. Allergy Clin. Immunol. 107:129-134.
29. Kerem, B., et al. 1989. Identification of the cystic fibrosis gene: genetic analysis. Science 245:1073-1080.
30. Lee, J. H., and D. J. O'Sullivan. 2010. Genomic insights into Bifidobacteria. Microbiol. Mol. Biol. Rev. 74:378-416.
31. Ley, R. E., et al. 2005. Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. U. S. A. 102:11070-11075.
32. Li, M., et al. 2009. Molecular diversity of Bacteroides spp. in human fecal microbiota as determined by group-specific 16S rRNA gene clone library analysis. Syst. Appl. Microbiol. 32:193-200.
33. Lucke, K., S. Miehlke, E. Jacobs, and M. Schuppler. 2006. Prevalence of Bacteroides and Prevotella spp. in ulcerative colitis. J. Med. Microbiol. 55:617-624.
34. Lupp, C., et al. 2007. Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host. Microbe 2:119-129.
35. Ly, N. P., et al. 2006. Mode of delivery and cord blood cytokines: a birth cohort study. Clin. Mol. Allergy 4:13.
36. Manichanh, C., et al. 2006. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 55:205-211.
37. Martinez, C., et al. 2008. Unstable composition of the fecal microbiota in ulcerative colitis during clinical remission. Am. J. Gastroenterol. 103:643-648.
38. Marzorati, M., L. Wittebolle, N. Boon, D. Daffonchio, and W. Verstraete. 2008. How to get more out of molecular fingerprints: practical tools for microbial ecology. Environ. Microbiol. 10:1571-1581.
39. Masco, L., G. Huys, D. Gevers, L. Verbrugghen, and J. Swings. 2003. Identification of Bifidobacterium species using rep-PCR fingerprinting. Syst. Appl. Microbiol. 26:557-563.
40. Modolell, I., L. Guarner, and J. R. Malagelada. 2002. Digestive system involvement in cystic fibrosis. Pancreatology 2:12-16.
41. Monreal, M. T., P. C. Pereira, and C. A. de Magalhaes Lopes. 2005. Intestinal microbiota of patients with bacterial infection of the respiratory tract treated with amoxicillin. Braz. J. Infect. Dis. 9:292-300.
42. Nord, C. E. 1993. The effect of antimicrobial agents on the ecology of the human intestinal microflora. Vet. Microbiol. 35:193-197.
43. O'Sullivan, D. J. 2000. Methods for analysis of the intestinal microflora. Curr. Issues Intest. Microbiol. 1:39-50.
44. Penders, J., et al. 2006. Molecular fingerprinting of the intestinal microbiota of infants in whom atopic eczema was or was not developing. Clin. Exp. Allergy 36:1602-1608.
45. Penders, J., E. E. Stobberingh, P. A. van den Brandt, and C. Thijs. 2007. The role of the intestinal microbiota in the development of atopic disorders. Allergy 62:1223-1236.
46. Penders, J., et al. 2006. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 118:511-521.
47. Picard, C., et al. 2005. Review article: bifidobacteria as probiotic agents- physiological effects and clinical benefits. Aliment Pharmacol. Ther. 22:495-512.
48. Pitcher, D. G., N. A. Saunders, and R. J. Owen. 1989. Rapid extraction of bacterial genomic DNA with guanidium thiocyanate. Lett. Appl. Microbiol. 8:151-156.
49. Preidis, G. A., and J. Versalovic. 2009. Targeting the human microbiome with antibiotics, probiotics, and prebiotics: gastroenterology enters the metagenomics era. Gastroenterology 136:2015-2031.
50. Proesmans, M., F. Vermeulen, and K. De Boeck. 2008. What's new in cystic fibrosis? From treating symptoms to correction of the basic defect. Eur. J. Pediatr. 167:839-849.
51. Rafii, F., J. B. Sutherland, and C. E. Cerniglia. 2008. Effects of treatment with antimicrobial agents on the human colonic microflora. Ther. Clin. Risk Manag. 4:1343-1358.
52. Rajilić-Stojanović, M., H. Smidt, and W. M. de Vos. 2007. Diversity of the human gastrointestinal tract microbiota revisited. Environ. Microbiol. 9:2125-2136.
53. Rogosa, M. 1956. A selective medium for the isolation and enumeration of the veillonella from the oral cavity. J. Bacteriol. 72:533-536.
54. Scanlan, P. D., F. Shanahan, C. O'Mahony, and J. R. Marchesi. 2007. Culture-independent analyses of temporal variation of the dominant fecal microbiota and targeted bacterial subgroups in Crohn's disease. J. Clin. Microbiol. 45:1671.
55. Schmitt-Grohé, S., E. Wiggert, J. Steffan, R. Handke, and S. Zielen. 2002. Severe antibiotic-associated colitis in a patient with cystic fibrosis and colonic wall thickening. J. Pediatr. Gastroenterol. Nutr. 34:224-226.
56. Sekirov, I., S. L. Russell, L. C. Antunes, and B. B. Finlay. 2010. Gut microbiota in health and disease. Physiol. Rev. 90:859-904.
57. Seksik, P., et al. 2003. Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut 52:237-242.
58. Sghir, A., et al. 2000. Quantification of bacterial groups within human fecal flora by oligonucleotide probe hybridization. Appl. Environ. Microbiol. 66: 2263-2266.
59. Stecher, B., and W. D. Hardt. 2008. The role of microbiota in infectious disease. Trends Microbiol. 16:107-114.
60. Swidsinski, A., et al. 2002. Mucosal flora in inflammatory bowel disease. Gastroenterology 122:44-54.
61. Tannock, G. W. 2002. Molecular methods for exploring the intestinal ecosystem. Br. J. Nutr. 87(Suppl. 2):S199-S201.
62. Temmerman, R., I. Scheirlinck, G. Huys, and J. Swings. 2003. Cultureindependent analysis of probiotic products by denaturing gradient gel electrophoresis. Appl. Environ. Microbiol. 69:220-226.
63. Turnbaugh, P. J., and J. I. Gordon. 2009. The core gut microbiome, energy balance and obesity. J. Physiol. 587:4153-4158.
64. Turroni, F., et al. 2009. Exploring the diversity of the bifidobacterial population in the human intestinal tract. Appl. Environ. Microbiol. 75: 1534-1545.
65. Vael, C., and K. Desager. 2009. The importance of the development of the intestinal microbiota in infancy. Curr. Opin. Pediatr. 21:794-800.
66. Van der Meulen, R., N. Camu, T. Van Vooren, C. Heymans, and L. De Vuyst. 2008. In vitro kinetic analysis of carbohydrate and aromatic amino acid metabolism of different members of the human colon. Int. J. Food Microbiol. 124:27-33.
67. Vanhoutte, T., G. Huys, E. De Brandt, and J. Swings. 2004. Temporal stability analysis of the microbiota in human feces by denaturing gradient gel electrophoresis using universal and group-specific 16S rRNA gene primers. FEMS Microbiol. Ecol. 48:437-446.
68. Vollaard, E. J., and H. A. L. Clasener. 1994. Colonization resistance-reply. Antimicrob. Agents Chemother. 38:1693.
69. Watanabe, S., et al. 2003. Differences in fecal microflora between patients with atopic dermatitis and healthy control subjects. J. Allergy Clin. Immunol. 111:587-591.
70. Weiss, B., et al. 2010. Probiotic supplementation affects pulmonary exacerbations in patients with cystic fibrosis: a pilot study. Pediatr. Pulmonol. 45:536-540.
71. Werlin, S. L., et al. 2010. Evidence of intestinal inflammation in patients with cystic fibrosis. J. Pediatr. Gastroenterol. Nutr. 51:304-308.
72. Wittebolle, L., et al. 2009. Initial community evenness favours functionality under selective stress. Nature 458:623-626.
73. Wu, X. K., et al. 2010. Molecular characterisation of the faecal microbiota in patients with type II diabetes. Curr. Microbiol. 61:69-78.
74. Yachi, S., and M. Loreau. 1999. Biodiversity and ecosystem productivity in a fluctuating environment: the insurance hypothesis. Proc. Natl. Acad. Sci. U. S. A. 96:1463-1468.
75. Yu, Z. T., and M. Morrison. 2004. Comparisons of different hypervariable regions of rrs genes for use in fingerprinting of microbial communities by PCR-denaturing gradient gel electrophoresis. Appl. Environ. Microbiol. 70:4800-4806.
76. Zoetendal, E. G., A. D. L. Akkermans, and W. M. De Vos. 1998. Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria. Appl. Environ. Microbiol. 64:3854-3859.